Postkidney Transplant Thrombotic Microangiopathy Effectively Treated with Eculizumab in a Tertiary Care Center

被引：0
|
作者：
Bharati, Joyita [1 ]
Francis, Jean M. [1 ]
Dickson, Justine Elyse [1 ]
机构：
[1] Boston Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024sn79t36y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PUB507
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature
    Hilburg, Rachel
    Geara, Abdallah S.
    Qiu, Maylene Kefeng
    Palmer, Matthew B.
    Chiang, Elaine Y.
    Burger, Robert A.
    Hogan, Jonathan J.
    CLINICAL NEPHROLOGY, 2021, 96 (01) : 51 - 59
  • [42] Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
    Pallotti, Federica
    Queffeulou, Claire
    Bellal, Mathieu
    Jean-Jacques, Bastien
    Gac, Anne-Claire
    Chatelet, Valerie
    Boyer, Annabel
    Gueutin, Victor
    KIDNEY AND DIALYSIS, 2022, 2 (04): : 625 - 637
  • [43] ACUTE KIDNEY INJURY DUE TO THROMBOTIC MICROANGIOPATHY FROM CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME TREATED WITH ECULIZUMAB
    Gudura, Tariku T.
    Sawaf, Hanny
    Herlitz, Leal
    Taliercio, Jonathan
    Nakhoul, Georges
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S71 - S71
  • [44] Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab
    Bhutani, Divaya
    Assal, Amer
    Mapara, Markus Y.
    Prinzing, Samantha
    Lentzsch, Suzanne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : E155 - E157
  • [45] Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
    Torres, Everardo Arias
    Chang, Yongen
    Desai, Sheetal
    Chang, Ian
    Zuckerman, Jonathan E.
    Burwick, Richard
    Kalantar-Zadeh, Kamyar
    Hanna, Ramy M.
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2021, 11 (01): : 95 - 102
  • [46] FAILURE OF ECULIZUMAB TREATMENT FOR THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH ACUTE HUMORAL REJECTION IN A RENAL TRANSPLANT RECIPIENT
    Karakizlis, H.
    Wolter, M.
    Groene, H. J.
    Wehling, C.
    Kirschfink, M.
    Padberg, W.
    Weimer, R.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 34 - 34
  • [47] FAILURE OF ECULIZUMAB TREATMENT FOR THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH ACUTE HUMORAL REJECTION IN A RENAL TRANSPLANT RECIPIENT
    Karakizlis, Hristos
    Wolter, Martin
    Groene, Hermann-Josef
    Wehling, Cyrill
    Kirschfink, Michael
    Padberg, Winfried
    Weimer, Rolf
    TRANSPLANT INTERNATIONAL, 2017, 30 : 530 - 530
  • [48] Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab
    Iqbal, Z.
    Wood, K.
    Carter, V.
    Goodship, T. H.
    Brown, A. L.
    Sheerin, N. S.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (07) : 2258 - 2261
  • [49] ECULIZUMAB FOR THE TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA)
    Thampi, Sheila
    Dvorak, Christopher
    Matthay, Katherine
    Horn, Biljana
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S104 - S105
  • [50] A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab
    Nozawa, Akifumi
    Ozeki, Michio
    Hori, Tomohiro
    Kawamoto, Norio
    Hirayama, Masahiro
    Azuma, Eiichi
    Fukao, Toshiyuki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (08) : e544 - e546
12345